Apellis Pharmaceuticals (APLS) PT Lowered to $48 at Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Derek Archila lowered the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $48.00 (from $57.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
